Drugs / Intra-vitreal Anti-VEGF Drug
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01640171 Background | Jul 2012 → Sep 2013 | age-related macular degeneration, central retinal vein occlusion, diabetic macular edema | Retina Vitreous Associates of Florida | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intra-vitreal Anti-VEGF Drug | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01640171 ↗ |
| Route | Intravitreal | “Intravitreal injection treating wet AMD or Diabetic Macular Edema or Retinal Vein Occlusion” NCT01640171 ↗ |